INVESTORS

Enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.

 

About Us

VaxCelerate Presentation
 Thursday, April 23, 2020

Dr. Mark Poznansky provided shareholders with an overview and update on VaxCelerate, a potential vaccine for COVID-19 and answered pre-submitted questions.